Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

Background Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. Methods and Results Major bleeding, subsequent myocardial infarction (MI), and all‐cause mortality to 1 year were compared in consecutive...

Full description

Bibliographic Details
Main Authors: Liam Mullen, Mohammed N. Meah, Ahmed Elamin, Suneil Aggarwal, Adeel Shahzad, Matthew Shaw, Jaroslav Hasara, Muhammad Rashid, Michael Fisher, Turab Ali, Billal Patel, Wern Y. Ding, Ruth Grainger, Thomas Heseltine, Bilal H. Kirmani, Mohammed Obeidat, Yande Kasolo, Jecko Thatchil, Aleem Khand
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
antiplatelet
bleeding
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.019467

Similar Items

Similar Items